The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
Deep TMS™ becomes first and only TMS device cleared in treatment of patients aged 15 to 86 suffering from depressionBURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay ...
Entered into an Agreement to be acquired by QOL MedicalNet product sales for the third quarter of 2025 reached $4.3 million; ...
The Speech Pathologists and Audiologists Association of Nigeria (SPAAN) has raised alarm over the growing prevalence of hearing and speech ...
Attention deficit hyperactivity disorder, or ADHD, is a long-term neurodevelopmental disorder usually found and diagnosed in ...
Scientists at Mayo Clinic have uncovered a rare genetic twist that challenges what we thought we knew about one of the world’s most common liver diseases.
Obesity is associated with some of the most serious health problems facing Americans, including Type 2 diabetes, high blood ...
BioRestorative Therapies, Inc. ('BioRestorative”, 'BRTX” or the 'Company”) (NASDAQ:BRTX), a regenerative medicine innovator ...
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company developing ...
Arista Recovery, a nationally recognized leader in behavioral health treatment, proudly announces the launch of Arista Recovery ? Hilliard, marking the organization's expansion into ...
Oregon health care providers who review every case in which a mother died during or soon after pregnancy have found that mental health conditions and substance use were the leading cause ...
Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply ...